126 related articles for article (PubMed ID: 35800205)
1. The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
Sun S; Wang X; Chen Y
Scanning; 2022; 2022():5648195. PubMed ID: 35800205
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
[TBL] [Abstract][Full Text] [Related]
3. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
4. The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
Yang E; Huang S; Ran X; Huang Y; Li Z
BMC Cancer; 2021 Feb; 21(1):203. PubMed ID: 33639874
[TBL] [Abstract][Full Text] [Related]
5. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
Chen C; Duan H; Zhang W; Zhao H; Wang L; Kang S; Lin L; Zhao W; Ni Y; Li D; Chen J; Fan H; Chen X; Bin X; Lang J; Liu P
BMC Cancer; 2021 Oct; 21(1):1091. PubMed ID: 34627169
[TBL] [Abstract][Full Text] [Related]
8. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
9. [Value of CT scanning in the diagnosis of early cervical carcinoma].
Dai JR; Zhang X; Jiang LX; Li J; Zhang J
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):151-4. PubMed ID: 16750026
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Sironi S; Buda A; Picchio M; Perego P; Moreni R; Pellegrino A; Colombo M; Mangioni C; Messa C; Fazio F
Radiology; 2006 Jan; 238(1):272-9. PubMed ID: 16304090
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of
Isaji Y; Tsuyoshi H; Tsujikawa T; Orisaka M; Okazawa H; Yoshida Y
Sci Rep; 2023 Nov; 13(1):18864. PubMed ID: 37914892
[TBL] [Abstract][Full Text] [Related]
13. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
[TBL] [Abstract][Full Text] [Related]
16. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
18. Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer.
Ito F; Sugiura A; Toyoda S; Itani Y; Iwai K; Yamada Y; Tanase Y; Kawaguchi R; Kobayashi H; Kita T
J Obstet Gynaecol Res; 2019 Jul; 45(7):1371-1375. PubMed ID: 31106933
[TBL] [Abstract][Full Text] [Related]
19. Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix.
Martínez A; Zerdoud S; Mery E; Bouissou E; Ferron G; Querleu D
Gynecol Oncol; 2010 Dec; 119(3):431-5. PubMed ID: 20822803
[TBL] [Abstract][Full Text] [Related]
20. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]